|
EIF1AD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.884800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.778000E-02 |
| Normal-vs-Stage2 |
1.018210E-01 |
| Normal-vs-Stage3 |
1.471940E-02 |
| Normal-vs-Stage4 |
2.742000E-02 |
| Stage1-vs-Stage2 |
3.394600E-01 |
| Stage1-vs-Stage3 |
5.484200E-02 |
| Stage1-vs-Stage4 |
3.375800E-02 |
| Stage2-vs-Stage3 |
5.932800E-01 |
| Stage2-vs-Stage4 |
2.935600E-01 |
| Stage3-vs-Stage4 |
5.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.419900E-03 |
| Normal-vs-AfricanAmerican |
9.574300E-02 |
| Normal-vs-Asian |
2.252200E-01 |
| Caucasian-vs-AfricanAmerican |
6.337200E-01 |
| Caucasian-vs-Asian |
4.176600E-01 |
| AfricanAmerican-vs-Asian |
3.051800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.524200E-02 |
| Normal-vs-Female |
4.819500E-03 |
| Male-vs-Female |
2.165800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.713960E-01 |
| Normal-vs-Extreme_Weight |
8.507600E-02 |
| Normal-vs-Obese |
2.460300E-03 |
| Normal-vs-Extreme_Obese |
7.740400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.622000E-01 |
| Normal_Weight-vs-Obese |
2.279000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.796400E-01 |
| Extreme_Weight-vs-Obese |
1.251960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.553600E-01 |
| Obese-vs-Extreme_Obese |
1.966650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.200600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.93169999999877E-05 |
| Normal-vs-Age(61-80Yrs) |
3.147800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.874800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.214400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.715730E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.562600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.396900E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.007600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.482050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.821000E-04 |
| Normal-VS-Type2 PRCC |
4.741200E-01 |
| Normal-VS-KIRP CIMP |
3.01729752294477E-11 |
| Normal-VS-Unclassified PRCC |
5.544000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.412800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.19689999999551E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.087400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.5315000096171E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.460130E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.61360000000044E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.439000E-01 |
| Normal-vs-N1 |
6.030200E-04 |
| Normal-vs-N2 |
5.868000E-01 |
| N0-vs-N1 |
6.296400E-03 |
| N0-vs-N2 |
7.586800E-01 |
| N1-vs-N2 |
4.599200E-01 |
|
|
